Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Sep 15, 2020; 12(9): 1031-1043
Published online Sep 15, 2020. doi: 10.4251/wjgo.v12.i9.1031
Published online Sep 15, 2020. doi: 10.4251/wjgo.v12.i9.1031
Figure 3 Comparison of computed tomography images of the liver lesion before and after long-acting repeatable octreotide treatment.
A and B: Pre-treatment images; C and D: Post-treatment images.
- Citation: Wang HH, Liu ZC, Zhang G, Li LH, Li L, Meng QB, Wang PJ, Shen DQ, Dang XW. Clinical characteristics and outcome of primary hepatic neuroendocrine tumors after comprehensive therapy. World J Gastrointest Oncol 2020; 12(9): 1031-1043
- URL: https://www.wjgnet.com/1948-5204/full/v12/i9/1031.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i9.1031